Skip to content

Lipiodol Localization for Ground-glass-opacity Minimal Surgery

Validation Study to Evaluate the Safety and Efficacy of Preoperative Computed Tomography-guided Localization Technique Using Lipiodol for Patients With Ground Glass Opacity Pulmonary Lesions: A Prospective Multicenter Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02180568
Acronym
LOGIS
Enrollment
250
Registered
2014-07-02
Start date
2014-05-31
Completion date
2017-12-31
Last updated
2018-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Lesion With Ground-glass-opacity

Keywords

Ground-glass-opacity (GGO), Lung localization, Lipiodol, Hook wire, Video assisted thoracic surgery (VATS)

Brief summary

The study object is to demonstrate the usefulness and safety of lipiodol localization technique for individuals undergoing ground-glass opacity (GGO) Video-assisted thoracic surgery (VATS) resection compared to hook wire localization technique. A total of 250 participants will be enrolled in a 1:1 fashion to Lipiodol or Hook-wire groups. If the aims of this study are achieved, the use of lipiodol localization technique will be widespread their application for localization of non-palpable pulmonary lesions that are indicated for VATS resection.

Interventions

PROCEDURELipiodol

Lipiodol-guided lung localization technique

PROCEDUREHookwire

Hookwire-guided lung localization technique

Sponsors

Gangnam Severance Hospital
CollaboratorOTHER
Asan Medical Center
CollaboratorOTHER
Pusan National University Hospital
CollaboratorOTHER
Korea University Anam Hospital
CollaboratorOTHER
Chung-Ang University Hosptial, Chung-Ang University College of Medicine
CollaboratorOTHER
Dankook University
CollaboratorOTHER
Wonju Severance Christian Hospital
CollaboratorOTHER
Severance Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Consenting adult patients ≥ 20 years of age * Pulmonary lesion with a ground glass opacity(GGO)component of more than 50% * Patient with lesion size less than 3cm * Persistence or growth of the established lesion within a three month period * Patient who are not contraindicated to surgery * Patients who are willing to sign the informed consent form

Exclusion criteria

* Patients with solid pulmonary lesion * Patients with multiple GGOs need multiple localization * Patients who are contraindicated to surgery * Patients who behave in an uncooperative manner * Unwilling or unable to give informed consent * Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Procedure success rateone dayProcedure success was defined as marking (lipiodol or hook-wire) the GGO lesion within 1 cm without pleural leakage of lipiodol or dislodgement of the hook-wire.

Secondary

MeasureTime frameDescription
Complication rateone dayProcedure-related complications such as pneumothorax, lung hemorrhage, hemoptysis, air-embolism and death
Procedure time1 hourTotal procedure time for lung localization
Surgery time12 hoursSurgery time for obtaining wedge resection specimen
Safety resection margin1 hourThe safety specimen resection margin was categorized either as positive (grossly positive (R2), microscopically positive if tumor was at the inked surface (R1)), or negative (microscopically negative if there was no tumor at the inked surface (R0))

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026